MULTIVALENT ANTIHELMINTHIC VACCINE
    2.
    发明申请
    MULTIVALENT ANTIHELMINTHIC VACCINE 有权
    多功能抗生素疫苗

    公开(公告)号:US20110200640A1

    公开(公告)日:2011-08-18

    申请号:US12999132

    申请日:2009-06-30

    IPC分类号: A61K39/002

    摘要: A multivalent anthelmintic vaccine targets both hookworm and schistosomiasis. The vaccine includes, at a minimum, a recombinant third-stage larval hookworm antigen, a recombinant adult stage hookworm antigen, and a recombinant schistosome antigen. Preferably, the hookworm antigens are Necator americanus antigens, although antigens from other hookworm species (e.g. Ancylostoma duodenale) may also be employed. The schistosome antigen is preferably a Schistosoma mansoni or a Schistosoma haematobium antigen although antigens from other schistosome species (e.g. Schistosoma japonicum) may also be employed. In some cases full or partial sequences of schistosome antigens may be fused with full or partial sequences of hookworm {Necator americanus) to produce recombinant chimeric antigens.

    摘要翻译: 一种多价驱虫肠炎疫苗靶向钩虫和血吸虫病。 该疫苗至少包含重组的第三代幼虫钩虫抗原,重组成虫阶段的钩虫抗原和重组血吸虫抗原。 优选地,钩虫抗原是美洲N虫抗原,尽管也可以使用来自其它钩虫属(例如十二指肠十二指肠)的抗原。 尽管也可以使用来自其它血吸虫物种(例如日本血吸虫)的抗原,血吸虫抗原优选为血吸虫血吸虫血吸虫血吸虫抗原。 在一些情况下,血吸虫抗原的全部或部分序列可以与钩虫(美洲{虫)的全部或部分序列融合以产生重组嵌合抗原。